Composition and method for aiding sleep
AssigneeSequential Medicine Limited
InventorLan Bo Chen
Life of this patent
Estimating the term…
Abstract
Described is a controlled-release formulation for treating disturbed sleep or insomnia in a subject. The formulation is formulated to release a compound or combination of compounds in sequence at multiple stages.
Claims7
A controlled-release formulation, comprising 50 mg of diphenhydramine HCl, 5 mg of zolpidem tartrate, and 0.5 mg of lorazepam, wherein the formulation is formulated for a first stage immediate release of the diphenhydramine HCl in a subject after the formulation is administered to the subject, a second stage release of the zolpidem tartrate that starts 2-3 hours after initiation of the first stage, and a third stage release of the lorazepam that starts 2-3 hours after initiation of the second stage.
Dependencies are inferred from the claim text.